DRUGS MADE IN AMERICA ACQUISITION II CORP.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $-116.7K | $17.0K |
| FY2025 | — | $-17.8M | $223 |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $-116.7K | $17.0K |
| FY2025 | — | $-17.8M | $223 |